1. Home
  2. BLCO vs MC Comparison

BLCO vs MC Comparison

Compare BLCO & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • MC
  • Stock Information
  • Founded
  • BLCO 1853
  • MC 2007
  • Country
  • BLCO Canada
  • MC United States
  • Employees
  • BLCO N/A
  • MC N/A
  • Industry
  • BLCO Ophthalmic Goods
  • MC Investment Managers
  • Sector
  • BLCO Health Care
  • MC Finance
  • Exchange
  • BLCO Nasdaq
  • MC Nasdaq
  • Market Cap
  • BLCO 4.0B
  • MC 4.6B
  • IPO Year
  • BLCO 2022
  • MC 2014
  • Fundamental
  • Price
  • BLCO $11.45
  • MC $57.10
  • Analyst Decision
  • BLCO Hold
  • MC Hold
  • Analyst Count
  • BLCO 12
  • MC 7
  • Target Price
  • BLCO $15.59
  • MC $59.83
  • AVG Volume (30 Days)
  • BLCO 850.1K
  • MC 839.6K
  • Earning Date
  • BLCO 04-30-2025
  • MC 07-23-2025
  • Dividend Yield
  • BLCO N/A
  • MC 4.55%
  • EPS Growth
  • BLCO N/A
  • MC N/A
  • EPS
  • BLCO N/A
  • MC 2.29
  • Revenue
  • BLCO $4,829,000,000.00
  • MC $1,283,653,000.00
  • Revenue This Year
  • BLCO $6.97
  • MC $10.42
  • Revenue Next Year
  • BLCO $5.44
  • MC $19.26
  • P/E Ratio
  • BLCO N/A
  • MC $24.96
  • Revenue Growth
  • BLCO 11.94
  • MC 45.14
  • 52 Week Low
  • BLCO $10.45
  • MC $47.00
  • 52 Week High
  • BLCO $21.69
  • MC $82.89
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 44.25
  • MC 50.00
  • Support Level
  • BLCO $10.99
  • MC $56.82
  • Resistance Level
  • BLCO $12.05
  • MC $58.45
  • Average True Range (ATR)
  • BLCO 0.41
  • MC 1.56
  • MACD
  • BLCO 0.08
  • MC -0.18
  • Stochastic Oscillator
  • BLCO 35.38
  • MC 31.22

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Share on Social Networks: